Early-Stage Hodgkin Lymphoma Outcomes After Combined Modality Therapy According to the Post-Chemotherapy 5-Point Score: Can Residual PET-Positive Disease Be Cured with Radiotherapy...

por Milgrom, S. A., Pinnix, C. C., Chuang, H., Oki, Y., Akhtari, M., Mawlawi, O., Garg, N., Gunther, J. R., Reddy, J. P., Smith, G. L., Rohren, E., Hagemeister, F. B., Lee, H. J., Fayad, L. E., Dong, W., Osborne, E. M., Yehia, Z. Abou, Fanale, M., Dabaja, B. S.
Publicado no Br J Haematol (2017)

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes

por Cheah, C. Y., Chihara, D., Horowitz, S., Sevin, A., Oki, Y., Zhou, S., Fowler, N. H., Romaguera, J. E., Turturro, F., Hagemeister, F. B., Fayad, L. E., Wang, M., Neelapu, S. S., Nastoupil, L. J., Westin, J. R., Rodriguez, M. A., Samaniego, F., Anderlini, P., Nieto, Y., Fanale, M. A.
Publicado no Ann Oncol (2016)

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome

por Vadhan-Raj, S., Fayad, L. E., Fanale, M. A., Pro, B., Rodriguez, A., Hagemeister, F. B., Bueso-Ramos, C. E., Zhou, X., McLaughlin, P. W., Fowler, N., Shah, J., Orlowski, R. Z., Samaniego, F., Wang, M., Cortes, J. E., Younes, A., Kwak, L. W., Sarlis, N. J., Romaguera, J. E.
Publicado em 2012

Encouraging activity for R-CHOP in advanced stage nodular lymphocyte–predominant Hodgkin lymphoma

por Fanale, Michelle A., Cheah, Chan Yoon, Rich, Amy, Medeiros, L. Jeffrey, Lai, Chao-Ming, Oki, Yasuhiro, Romaguera, Jorge E., Fayad, Luis E., Hagemeister, F. B., Samaniego, Felipe, Rodriguez, Maria A., Neelapu, Sattva S., Lee, Hun J., Nastoupil, Loretta, Fowler, Nathan H., Turturro, Francesco, Westin, Jason R., Wang, Michael L., McLaughlin, Peter, Pinnix, Chelsea C., Milgrom, Sarah A., Dabaja, Bouthaina, Horowitz, Sandra B., Younes, Anas
Publicado no Blood (2017)